This report contains market size and forecasts of Immuno-Oncology in Global, including the following market information:
Global Immuno-Oncology Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Immuno-Oncology market was valued at 39050 million in 2020 and is projected to reach US$ 66550 million by 2027, at a CAGR of 14.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immuno-Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immuno-Oncology Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Immuno-Oncology Market Segment Percentages, By Type, 2020 (%)
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
China Immuno-Oncology Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Immuno-Oncology Market Segment Percentages, By Application, 2020 (%)
Hospitals
Drugstores
Others
Global Immuno-Oncology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Immuno-Oncology Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Immuno-Oncology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Immuno-Oncology Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Immuno-Oncology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immuno-Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immuno-Oncology Overall Market Size
2.1 Global Immuno-Oncology Market Size: 2021 VS 2027
2.2 Global Immuno-Oncology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immuno-Oncology Players in Global Market
3.2 Top Global Immuno-Oncology Companies Ranked by Revenue
3.3 Global Immuno-Oncology Revenue by Companies
3.4 Top 3 and Top 5 Immuno-Oncology Companies in Global Market, by Revenue in 2020
3.5 Global Companies Immuno-Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-Oncology Players in Global Market
3.6.1 List of Global Tier 1 Immuno-Oncology Companies
3.6.2 List of Global Tier 2 and Tier 3 Immuno-Oncology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immuno-Oncology Market Size Markets, 2021 & 2027
4.1.2 Immune Checkpoint Inhibitors
4.1.3 Cytokine-Based Immunotherapy
4.1.4 Cancer Vaccines
4.1.5 CAR-T Cell Therapy
4.1.6 Others
4.2 By Type - Global Immuno-Oncology Revenue & Forecasts
4.2.1 By Type - Global Immuno-Oncology Revenue, 2016-2021
4.2.2 By Type - Global Immuno-Oncology Revenue, 2022-2027
4.2.3 By Type - Global Immuno-Oncology Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immuno-Oncology Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Immuno-Oncology Revenue & Forecasts
5.2.1 By Application - Global Immuno-Oncology Revenue, 2016-2021
5.2.2 By Application - Global Immuno-Oncology Revenue, 2022-2027
5.2.3 By Application - Global Immuno-Oncology Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Immuno-Oncology Market Size, 2021 & 2027
6.2 By Region - Global Immuno-Oncology Revenue & Forecasts
6.2.1 By Region - Global Immuno-Oncology Revenue, 2016-2021
6.2.2 By Region - Global Immuno-Oncology Revenue, 2022-2027
6.2.3 By Region - Global Immuno-Oncology Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Immuno-Oncology Revenue, 2016-2027
6.3.2 US Immuno-Oncology Market Size, 2016-2027
6.3.3 Canada Immuno-Oncology Market Size, 2016-2027
6.3.4 Mexico Immuno-Oncology Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Immuno-Oncology Revenue, 2016-2027
6.4.2 Germany Immuno-Oncology Market Size, 2016-2027
6.4.3 France Immuno-Oncology Market Size, 2016-2027
6.4.4 U.K. Immuno-Oncology Market Size, 2016-2027
6.4.5 Italy Immuno-Oncology Market Size, 2016-2027
6.4.6 Russia Immuno-Oncology Market Size, 2016-2027
6.4.7 Nordic Countries Immuno-Oncology Market Size, 2016-2027
6.4.8 Benelux Immuno-Oncology Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Immuno-Oncology Revenue, 2016-2027
6.5.2 China Immuno-Oncology Market Size, 2016-2027
6.5.3 Japan Immuno-Oncology Market Size, 2016-2027
6.5.4 South Korea Immuno-Oncology Market Size, 2016-2027
6.5.5 Southeast Asia Immuno-Oncology Market Size, 2016-2027
6.5.6 India Immuno-Oncology Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Immuno-Oncology Revenue, 2016-2027
6.6.2 Brazil Immuno-Oncology Market Size, 2016-2027
6.6.3 Argentina Immuno-Oncology Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immuno-Oncology Revenue, 2016-2027
6.7.2 Turkey Immuno-Oncology Market Size, 2016-2027
6.7.3 Israel Immuno-Oncology Market Size, 2016-2027
6.7.4 Saudi Arabia Immuno-Oncology Market Size, 2016-2027
6.7.5 UAE Immuno-Oncology Market Size, 2016-2027
7 Players Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Corporate Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Immuno-Oncology Major Product Offerings
7.1.4 Bristol-Myers Squibb Immuno-Oncology Revenue in Global (2016-2021)
7.1.5 Bristol-Myers Squibb Key News
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Corporate Summary
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. Immuno-Oncology Major Product Offerings
7.2.4 Merck & Co., Inc. Immuno-Oncology Revenue in Global (2016-2021)
7.2.5 Merck & Co., Inc. Key News
7.3 Roche AG
7.3.1 Roche AG Corporate Summary
7.3.2 Roche AG Business Overview
7.3.3 Roche AG Immuno-Oncology Major Product Offerings
7.3.4 Roche AG Immuno-Oncology Revenue in Global (2016-2021)
7.3.5 Roche AG Key News
7.4 AstraZeneca, Plc
7.4.1 AstraZeneca, Plc Corporate Summary
7.4.2 AstraZeneca, Plc Business Overview
7.4.3 AstraZeneca, Plc Immuno-Oncology Major Product Offerings
7.4.4 AstraZeneca, Plc Immuno-Oncology Revenue in Global (2016-2021)
7.4.5 AstraZeneca, Plc Key News
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Corporate Summary
7.5.2 Sanofi S.A. Business Overview
7.5.3 Sanofi S.A. Immuno-Oncology Major Product Offerings
7.5.4 Sanofi S.A. Immuno-Oncology Revenue in Global (2016-2021)
7.5.5 Sanofi S.A. Key News
7.6 Dendreon Pharmaceuticals
7.6.1 Dendreon Pharmaceuticals Corporate Summary
7.6.2 Dendreon Pharmaceuticals Business Overview
7.6.3 Dendreon Pharmaceuticals Immuno-Oncology Major Product Offerings
7.6.4 Dendreon Pharmaceuticals Immuno-Oncology Revenue in Global (2016-2021)
7.6.5 Dendreon Pharmaceuticals Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Immuno-Oncology Major Product Offerings
7.4.4 Novartis Immuno-Oncology Revenue in Global (2016-2021)
7.7.5 Novartis Key News
7.8 Gilead Sciences Inc.
7.8.1 Gilead Sciences Inc. Corporate Summary
7.8.2 Gilead Sciences Inc. Business Overview
7.8.3 Gilead Sciences Inc. Immuno-Oncology Major Product Offerings
7.8.4 Gilead Sciences Inc. Immuno-Oncology Revenue in Global (2016-2021)
7.8.5 Gilead Sciences Inc. Key News
7.9 Merck KGaA
7.9.1 Merck KGaA Corporate Summary
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Immuno-Oncology Major Product Offerings
7.9.4 Merck KGaA Immuno-Oncology Revenue in Global (2016-2021)
7.9.5 Merck KGaA Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Immuno-Oncology Market Opportunities & Trends in Global Market
Table 2. Immuno-Oncology Market Drivers in Global Market
Table 3. Immuno-Oncology Market Restraints in Global Market
Table 4. Key Players of Immuno-Oncology in Global Market
Table 5. Top Immuno-Oncology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Immuno-Oncology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Immuno-Oncology Revenue Share by Companies, 2016-2021
Table 8. Global Companies Immuno-Oncology Product Type
Table 9. List of Global Tier 1 Immuno-Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immuno-Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type